Rutgers Cancer Institute of New Jersey ( Site 0052)

New Brunswick, New Jersey 08903

2 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Malignant Neoplasm

Studies at this site

• A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001) — Recruiting now
• Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009) — Recruiting now